纪念斯隆凯特琳癌症中心(MSK)的研究团队于2026年10月7日在《自然》杂志发表成果,成功解析了免疫系统中一个悬而未决三十年的分子机制 1。该研究由Yanan Ma、Miklos Lengyel和Philipp Niethammer等人主导,证实负责招募免疫细胞以对抗感染的化学信号分子5-oxoETE及其生成酶DHRS7,实际上也承担着保护健康组织免受过度炎症损伤的双重功能 1。这一发现不仅解决了自1992年以来关于关键酶来源的生物学谜题,还为治疗癌症、炎症性肠病及哮喘等与炎症相关的疾病提供了新的潜在靶点 1。
研究人员识别出人类基因DHRS7是分解和合成5-oxoETE的关键酶来源,此前该基因的功能长期未被确认 1。由于小鼠缺乏能够识别5-oxoE的受体OXER1,无法完全重现这一生理过程,因此团队采用斑马鱼作为替代模型进行深入探索 1。实验数据显示,5-oxoETE信号通路不仅能吸引免疫细胞,还能通过激活NUDIX水解酶来保护上皮细胞免受化学应激损伤;若破坏该通路,即便在没有感染的情况下,肠道也会发生炎症,这证明了其具有固有的抗炎保护作用 1。此外,DHRS7和OXER1的突变已在胃肠道和子宫肿瘤中被发现,并与结直肠癌、胰腺癌及肾癌的较差预后密切相关 1。
Scientists at Memorial Sloan Kettering Cancer Center have resolved a biological puzzle dating back to 1992 by identifying the enzyme responsible for producing and breaking down a key immune signaling molecule 1. The study, published in Nature on October 7, 2026, reveals that the human gene DHRS7 generates the critical enzymes needed to synthesize and degrade 5-oxoETE, a chemical signal long known to recruit immune cells to fight infections 1. This discovery uncovers a dual function for the 5-oxoETE pathway: while it attracts immune defenders, it simultaneously protects healthy tissue from excessive inflammatory damage 1.
The research team, including Yanan Ma, Miklos Lengyel, and Philipp Niethammer, utilized zebrafish as a model organism because mice lack the OXER1 receptor required to detect 5-oxoE, making them unsuitable for fully replicating this specific process 1. By using zebrafish, the scientists demonstrated that the 5-oxoETE pathway activates NUDIX hydrolases, which shield epithelial cells from chemical stress 1. When this protective pathway was disrupted in the models, inflammation occurred in the intestines even without any infection, proving that the mechanism serves an inherent anti-inflammatory role 1.
Beyond its physiological functions, the study links genetic variations in DHRS7 and OXER1 to significant clinical outcomes 1. Mutations in these genes were found in gastrointestinal and uterine tumors, where they correlated with poorer prognoses in patients suffering from colorectal cancer, pancreatic cancer, and kidney cancer 1. These findings offer new potential therapeutic targets for treating inflammation-related conditions such as cancer, inflammatory bowel disease, and asthma 1.
评论
还没有评论,欢迎留下第一条。